
2.29 Delayed Data As of 12:00am ET | ![]() Today’s Change | 1.79 Today|||52-Week Range 21.75 | -8.40% Year-to-Date |
There is no forecast data available.
The current consensus among 1 polled investment analysts is to Hold stock in PharmaCyte Biotech Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.